Serum androgen concentrations and subclinical measures of cardiovascular disease in men and women

Atherosclerosis

Volumn 247, Issue , 2016, Pages 193-200

  Kische, Hanna ^a   Gross, Stefan ^b,d   Wallaschofski, Henri ^a,b   Völzke, Henry ^b,c   Dörr, Marcus ^b,d   Nauck, Matthias ^a,b   Felix, Stephan B ^b,d   Haring, Robin ^a,e  

^a Inst of Clinical Chemistry and Laboratory Medicine   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c Institute for Community Medicine   (Germany)

^d UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^e University of Applied Sciences Technology Business and Design   (Germany)

Author keywords

Androgens; Epidemiology; Sex hormone binding globulin; Subclinical cardiovascular disease

Indexed keywords

ANDROSTENEDIONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; ANDROGEN; BIOLOGICAL MARKER;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; FEMALE; FOLLOW UP; FRACTIONAL SHORTENING; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE REMODELING; HUMAN; LEFT VENTRICULAR GEOMETRY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELATIVE WALL THICKNESS; TANDEM MASS SPECTROMETRY; TESTOSTERONE BLOOD LEVEL; AGED; ASYMPTOMATIC DISEASE; BLOOD; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; GERMANY; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; RISK FACTOR; SEX DIFFERENCE; TIME FACTOR;

AGED; ANDROGENS; ANDROSTENEDIONE; ASYMPTOMATIC DISEASES; BIOMARKERS; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, LIQUID; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; SEX HORMONE-BINDING GLOBULIN; TANDEM MASS SPECTROMETRY; TESTOSTERONE; TIME FACTORS;

EID: 84959120344     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.02.020     Document Type: Article

References (49)

1. Cheng S., Xanthakis V., Sullivan L.M., Lieb W., Massaro J., Aragam J., Benjamin E.J., Vasan R.S. Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham heart study. Circulation 2010, 122:570-578.
2. Galderisi M., Vitale G., Lupoli G., Barbieri M., Varricchio G., Carella C., de Divitiis O., Paolisso G. Inverse association between free insulin-like growth factor-1 and isovolumic relaxation in arterial systemic hypertension. Hypertension 2001, 38:840-845.
3. Eller N.H., Netterstrom B., Allerup P. Progression in intima media thickness-the significance of hormonal biomarkers of chronic stress. Psychoneuroendocrinology 2005, 30:715-723.
4. Hayward C.S., Webb C.M., Collins P. Effect of sex hormones on cardiac mass. Lancet Lond.n, Engl. 2001, 357:1354-1356.
5. Haines C.D., Harvey P.A., Leinwand L.A. Estrogens mediate cardiac hypertrophy in a stimulus-dependent manner. Endocrinology 2012, 153:4480-4490.
6. Chan Y.X., Knuiman M.W., Hung J., Divitini M.L., Handelsman D.J., Beilby J.P., McQuillan B., Yeap B.B. Testosterone, dihydrotestosterone and estradiol are differentially associated with carotid intima-media thickness and the presence of carotid plaque in men with and without coronary artery disease. Endocr. J. 2015, 62:777-786.
7. Vikan T., Johnsen S.H., Schirmer H., Njolstad I., Svartberg J. Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromso study. Eur. J. Epidemiol. 2009, 24:289-295.
8. Svartberg J., von Muhlen D., Mathiesen E., Joakimsen O., Bonaa K.H., Stensland-Bugge E. Low testosterone levels are associated with carotid atherosclerosis in men. J. Intern. Med. 2006, 259:576-582.
9. Ouyang P., Vaidya D., Dobs A., Golden S.H., Szklo M., Heckbert S.R., Kopp P., Gapstur S.M. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the multi-ethnic study of atherosclerosis. Atherosclerosis 2009, 204:255-261.
10. El Khoudary S.R., Wildman R.P., Matthews K., Thurston R.C., Bromberger J.T., Sutton-Tyrrell K. Endogenous sex hormones impact the progression of subclinical atherosclerosis in women during the menopausal transition. Atherosclerosis 2012, 225:180-186.
11. Matsumoto A.M., Bremner W.J. Serum testosterone assays-accuracy matters. J. Clin. Endocrinol. Metab. 2004, 89:520-524.
12. Volzke H., Alte D., Schmidt C.O., Radke D., Lorbeer R., Friedrich N., Aumann N., Lau K., Piontek M., Born G., Havemann C., Ittermann T., Schipf S., Haring R., Baumeister S.E., Wallaschofski H., Nauck M., Frick S., Arnold A., Junger M., Mayerle J., Kraft M., Lerch M.M., Dorr M., Reffelmann T., Empen K., Felix S.B., Obst A., Koch B., Glaser S., Ewert R., Fietze I., Penzel T., Doren M., Rathmann W., Haerting J., Hannemann M., Ropcke J., Schminke U., Jurgens C., Tost F., Rettig R., Kors J.A., Ungerer S., Hegenscheid K., Kuhn J.P., Kuhn J., Hosten N., Puls R., Henke J., Gloger O., Teumer A., Homuth G., Volker U., Schwahn C., Holtfreter B., Polzer I., Kohlmann T., Grabe H.J., Rosskopf D., Kroemer H.K., Kocher T., Biffar R., John U., Hoffmann W. Cohort profile: the study of health in pomerania. Int. J. Epidemiol. 2011 Apr, 40(2):294-307. 10.1093/ije/dyp394.
13. Schwarz S., Volzke H., Alte D., Schwahn C., Grabe H.J., Hoffmann W., John U., Doren M. Menopause and determinants of quality of life in women at midlife and beyond: the study of health in pomerania (SHIP). Menopause 2007, 14:123-134. (New York, N.Y.).
14. Haring R., Hannemann A., John U., Radke D., Nauck M., Wallaschofski H., Owen L., Adaway J., Keevil B.G., Brabant G. Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry. J. Clin. Endocrinol. Metab. 2012, 97:408-415.
15. Thienpont L.M., Van Uytfanghe K., Blincko S., Ramsay C.S., Xie H., Doss R.C., Keevil B.G., Owen L.J., Rockwood A.L., Kushnir M.M., Chun K.Y., Chandler D.W., Field H.P., Sluss P.M. State-of-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tandem mass spectrometry. Clin. Chem. 2008, 54:1290-1297.
16. Vermeulen A., Verdonck L., Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 1999, 84:3666-3672.
17. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., Stewart W.J. Recommendations for chamber quantification: a report from the American society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J. Am. Soc. Echocardiogr. Off. Publ. Am. Soc. Echocardiogr. 2005, 18:1440-1463.
18. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J., Solomon S., Spencer K.T., St John Sutton M., Stewart W. Recommendations for chamber quantification. Eur. J. Echocardiogr. J. Work. Group Echocardiogr. Eur. Soc. Cardiol. 2006, 7:79-108.
19. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007, 370:1453-1457.
20. Lieb W., Xanthakis V., Sullivan L.M., Aragam J., Pencina M.J., Larson M.G., Benjamin E.J., Vasan R.S. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study. Circulation 2009, 119:3085-3092.
21. Bhasin S., Pencina M., Jasuja G.K., Travison T.G., Coviello A., Orwoll E., Wang P.Y., Nielson C., Wu F., Tajar A., Labrie F., Vesper H., Zhang A., Ulloor J., Singh R., D'Agostino R., Vasan R.S. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J. Clin. Endocrinol. Metab. 2011, 96:2430-2439.
22. Zitzmann M. The role of the CAG repeat androgen receptor polymorphism in andrology. Front. Horm. Res. 2009, 37:52-61.
23. La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991, 352:77-79.
24. Voigt C., Goymann W. Sex-role reversal is reflected in the brain of African black coucals (Centropus grillii). Dev. Neurobiol. 2007, 67:1560-1573.
25. Iemolo F., Martiniuk A., Steinman D.A., Spence J.D. Sex differences in carotid plaque and stenosis. Stroke. a J. Cereb. Circ. 2004, 35:477-481.
26. Kelly D.M., Jones T.H. Testosterone and cardiovascular risk in men. Front. Horm. Res. 2014, 43:1-20.
27. Alkamel A., Shafiee A., Jalali A., Boroumand M., Nozari Y. The association between premature coronary artery disease and level of testosterone in young adult males. Arch. Iran. Med. 2014, 17:545-550.
28. Rexrode K.M., Manson J.E., Lee I.M., Ridker P.M., Sluss P.M., Cook N.R., Buring J.E. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003, 108:1688-1693.
29. Patel S.M., Ratcliffe S.J., Reilly M.P., Weinstein R., Bhasin S., Blackman M.R., Cauley J.A., Sutton-Tyrrell K., Robbins J., Fried L.P., Cappola A.R. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J. Clin. Endocrinol. Metab. 2009, 94:4776-4784.
30. Burger H.G., Dudley E.C., Cui J., Dennerstein L., Hopper J.L. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J. Clin. Endocrinol. Metab. 2000, 85:2832-2838.
31. Sutton-Tyrrell K., Wildman R.P., Matthews K.A., Chae C., Lasley B.L., Brockwell S., Pasternak R.C., Lloyd-Jones D., Sowers M.F., Torrens J.I. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005, 111:1242-1249.
32. Rosano G.M., Leonardo F., Pagnotta P., Pelliccia F., Panina G., Cerquetani E., della Monica P.L., Bonfigli B., Volpe M., Chierchia S.L. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 1999, 99:1666-1670.
33. Saltiki K., Stamatelopoulos K., Voidonikola P., Lazaros L., Mantzou E., Georgiou I., Anastasiou E., Papamichael C., Alevizaki M. Association of the SHBG gene promoter polymorphism with early markers of atherosclerosis in apparently healthy women. Atherosclerosis 2011, 219:205-210.
34. Hammes A., Andreassen T.K., Spoelgen R., Raila J., Hubner N., Schulz H., Metzger J., Schweigert F.J., Luppa P.B., Nykjaer A., Willnow T.E. Role of endocytosis in cellular uptake of sex steroids. Cell 2005, 122:751-762.
35. Rosner W., Hryb D.J., Khan M.S., Nakhla A.M., Romas N.A. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J. Steroid Biochem. Mol. Biol. 1999, 69:481-485.
36. Brand J.S., van der Schouw Y.T. Testosterone, SHBG and cardiovascular health in postmenopausal women. Int. J. Impot. Res. 2010, 22:91-104.
37. Mitchell L.E., Sprecher D.L., Borecki I.B., Rice T., Laskarzewski P.M., Rao D.C. Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males. Circulation 1994, 89:89-93.
38. Barrett-Connor E., Goodman-Gruen D. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study. Circulation 1995, 91:1757-1760.
39. Reinecke H., Bogdanski J., Woltering A., Breithardt G., Assmann G., Kerber S., von Eckardstein A. Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women. Am. J. Cardiol. 2002, 90:364-368.
40. Berdanier C.D., Parente J.A., McIntosh M.K. Is dehydroepiandrosterone an antiobesity agent?. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 1993, 7:414-419.
41. Hougaku H., Fleg J.L., Najjar S.S., Lakatta E.G., Harman S.M., Blackman M.R., Metter E.J. Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E234-E242.
42. Calderon-Margalit R., Schwartz S.M., Wellons M.F., Lewis C.E., Daviglus M.L., Schreiner P.J., Williams O.D., Sternfeld B., Carr J.J., O'Leary D.H., Sidney S., Friedlander Y., Siscovick D.S. Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the "coronary artery risk development in young adults" women's study. J. Clin. Endocrinol. Metab. 2010, 95:4424-4431.
43. Harman S.M., Metter E.J., Tobin J.D., Pearson J., Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. J. Clin. Endocrinol. Metab. 2001, 86:724-731.
44. Haring R., Teng Z., Xanthakis V., Coviello A., Sullivan L., Bhasin S., Murabito J.M., Wallaschofski H., Vasan R.S. Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham heart study. Clin. Endocrinol. (Oxf.) 2013, 78:629-634.
45. Hildrum B., Mykletun A., Hole T., Midthjell K., Dahl A.A. Age-specific prevalence of the metabolic syndrome defined by the international diabetes federation and the national cholesterol education program: the Norwegian HUNT 2 study. BMC Public Health 2007, 7:220.
46. Langsted A., Freiberg J.J., Nordestgaard B.G. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008, 118:2047-2056.
47. Friedrich N., Volzke H., Rosskopf D., Steveling A., Krebs A., Nauck M., Wallaschofski H. Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men. J. Androl. 2008, 29:610-617.
48. Dumitrescu R., Mehedintu C., Briceag I., Purcarea V.L., Hudita D. The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms. J. Med. Life 2015, 8:142-145.
49. Basaria S., Harman S.M., Travison T.G., Hodis H., Tsitouras P., Budoff M., Pencina K.M., Vita J., Dzekov C., Mazer N.A., Coviello A.D., Knapp P.E., Hally K., Pinjic E., Yan M., Storer T.W., Bhasin S. Effects of testosterone administration for 3 years on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels: a randomized clinical trial. Jama 2015, 314:570-581.